Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin–unresponsive Carcinoma in Situ of the Bladder
Amanda A. Myers, Ruchika Talwar, Zhigang Duan, Patrick J. Hensley, Yair Lotan, Stephen B. Williams, Amy N. Luckenbaugh, Roger Li, Wassim Kassouf, Andrea Necchi, Vignesh T. Packiam, Neal D. Shore, Gary D. Steinberg, J. Alfred Witjes, Bogdana Schmidt, Sima P. Porten, Noah M. Hahn, Kelly K. Bree, Iakovos Toumazis, Hui Zhao, Ashish M. Kamat
Topics & Concepts
MedicinePembrolizumabCarcinoma in situCarcinomaBacillus (shape)Selection (genetic algorithm)Internal medicineOncologyIn situUrologyIntensive care medicineBladder cancerSurgeryMEDLINEFirst lineLine (geometry)Cost benefitBladder and Urothelial Cancer TreatmentsImmune responses and vaccinationsUrinary and Genital Oncology Studies